Who
Anabella Villalobos
Director
Company insider
Files Form 4 as: Director, Coya Therapeutics.
In numbers
- Trades disclosed
- 7
- Buys
- 1
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 3 Jan 2023
- Last trade
- 2 Jan 2026
- Last filed
- 6 Jan 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Jan 2026filed 6 Jan 2026 | COYA Coya Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | COYA Coya Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 25 Feb 2025filed 25 Feb 2025 | COYA Coya Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,000 at $0.00 | filing |
| 1 Jan 2025filed 3 Jan 2025 | COYA Coya Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,000 at $0.00 | filing |
| 1 Jan 2024filed 19 Jan 2024 | COYA Coya Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,000 at $0.00 | filing |
| 3 Jan 2023filed 4 Jan 2023 | COYA Coya Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code P | —5,000 | filing |
| 3 Jan 2023filed 4 Jan 2023 | COYA Coya TherapeuticsBiotechnology | SEC FORM 4 Bought | —10,000 | filing |
News
Madrigal Pharmaceuticals (NASDAQ:MDGL) & Coya Therapeutics (NASDAQ:COYA) Critical ContrastCOYA · themarketsdaily.com · 9 Oct 2026
0 headlines in the last 90 days name Anabella Villalobos; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.